Published in Arch Cardiovasc Dis on November 17, 2008
Updates in cardiac amyloidosis: a review. J Am Heart Assoc (2012) 2.21
Al amyloidosis. Orphanet J Rare Dis (2012) 1.29
Bilateral kidney infarction due to primary Al amyloidosis: a first case report. Medicine (Baltimore) (2015) 0.80
Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience. World J Transplant (2016) 0.77
Heart transplantation in cardiac amyloidosis. Heart Fail Rev (2017) 0.75
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med (2007) 5.84
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol (2012) 3.35
Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 2.63
Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol (2010) 2.51
Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet (2004) 2.31
Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab (2014) 2.17
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol (2011) 2.06
[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]. Presse Med (2013) 2.00
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood (2005) 1.99
Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis (2008) 1.93
Reoperation for false aneurysm of the ascending aorta after its prosthetic replacement: surgical strategy. Ann Thorac Surg (2005) 1.76
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood (2012) 1.75
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood (2012) 1.73
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. J Clin Oncol (2008) 1.65
Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis (2009) 1.62
Cardiac surgery in nonagenarians: hospital mortality and long-term follow-up. Interact Cardiovasc Thorac Surg (2006) 1.54
Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail (2009) 1.48
Single-centre experience with the Thoratec paracorporeal ventricular assist device for patients with primary cardiac failure. Arch Cardiovasc Dis (2009) 1.42
Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients. J Nucl Cardiol (2010) 1.41
Chronic dissection of the ascending aorta: surgical results during a 20-year period (previous surgery excluded). Eur J Cardiothorac Surg (2006) 1.40
CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment. Leuk Lymphoma (2014) 1.40
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol (2011) 1.38
Lower circulating Sta-Liatest D-Di levels in patients with aortic intramural hematoma compared with classical aortic dissection. Crit Care Med (2009) 1.38
Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med (2007) 1.34
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study. Blood (2010) 1.34
How I treat monoclonal gammopathy of renal significance (MGRS). Blood (2013) 1.33
Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association? Clin J Am Soc Nephrol (2011) 1.31
Al amyloidosis. Orphanet J Rare Dis (2012) 1.29
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med (2012) 1.26
Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis (2013) 1.26
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant (2002) 1.23
Surgical treatment of a pulmonary artery aneurysm. Eur J Cardiothorac Surg (2007) 1.21
Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int (2002) 1.18
Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation (2006) 1.15
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation (2003) 1.13
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients. Am J Hematol (2013) 1.11
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther (2004) 1.10
Diagnostic and prognostic value of circulating D-Dimers in patients with acute aortic dissection. Crit Care Med (2006) 1.06
C3 glomerulopathy in adults: monoclonal gammopathy should be considered. Am J Kidney Dis (2013) 1.05
18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid (2012) 1.05
Mitral valve repair for commissural prolapse: surgical techniques and long term results. Eur J Cardiothorac Surg (2005) 1.05
Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. Am J Kidney Dis (2005) 1.03
Results from a prospective, open-label, phase II trial of bendamustine in refractory or relapsed T-cell lymphomas: the BENTLY trial. J Clin Oncol (2012) 1.03
Mitral annulus calcification: determinants of repair feasibility, early and late surgical outcome. Eur J Cardiothorac Surg (2007) 1.03
Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol (2011) 1.02
Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation (2003) 1.02
A new method for measurement of left atrial volumes using 64-slice spiral computed tomography: comparison with two-dimensional echocardiographic techniques. Int J Cardiol (2008) 1.01
Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant (2010) 1.01
The left atrial appendage, a small, blind-ended structure: a review of its echocardiographic evaluation and its clinical role. Chest (2005) 1.00
Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease. Muscle Nerve (2006) 1.00
Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection. J Heart Lung Transplant (2008) 0.99
Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol (2011) 0.99
Acute pulmonary embolism: a current surgical approach. Interact Cardiovasc Thorac Surg (2006) 0.99
Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging (2013) 0.97
Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation. Transplantation (2003) 0.96
Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection. Antiviral Res (2008) 0.96
Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. Eur J Cardiothorac Surg (2009) 0.96
Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg (2009) 0.95
SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitié hospital. Ann Thorac Surg (2013) 0.94
Acute poststernotomy mediastinitis managed with debridement and closed-drainage aspiration: factors associated with death in the intensive care unit. J Thorac Cardiovasc Surg (2005) 0.94
Posterior reversible encephalopathy induced by intravenous immunoglobulin. Nephrol Dial Transplant (2007) 0.93
Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients. Transplantation (2009) 0.91
Patients with a body surface area less than 1.7 m2 have a good outcome with the CardioWest Total Artificial Heart. J Heart Lung Transplant (2005) 0.91
Real three-dimensional assessment of left atrial and left atrial appendage volumes by 64-slice spiral computed tomography in individuals with or without cardiovascular disease. Int J Cardiol (2008) 0.89
The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction. Basic Res Cardiol (2014) 0.89
Papillary muscle approximation for functional ischemic mitral regurgitation. Ann Thorac Surg (2007) 0.89
Chylothorax and re-expansion pulmonary edema following myocardial re-vascularization: role of lymph vessel insufficiency. Interact Cardiovasc Thorac Surg (2004) 0.89
Aortic prosthetic ring annuloplasty: a useful adjunct to a standardized aortic valve-sparing procedure? Eur J Cardiothorac Surg (2006) 0.89
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol (2012) 0.88
Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg (2007) 0.88
Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome. Blood (2006) 0.88
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma. Haematologica (2006) 0.87
Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients. Transpl Int (2009) 0.87
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Ann Rheum Dis (2012) 0.87
Persistent symptomatic pleural effusion following coronary bypass surgery: clinical and histologic features, and treatment. Heart Vessels (2007) 0.87
Quantitative regional analysis of left atrial function by Doppler tissue imaging-derived parameters discriminates patients with posterior and anterior myocardial infarction. J Am Soc Echocardiogr (2005) 0.86
Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant (2007) 0.86
Papillary necrosis following segmental renal infarction: an unusual cause of early renal allograft dysfunction. Nephrol Dial Transplant (2005) 0.86
Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients. Am J Kidney Dis (2013) 0.86
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant (2009) 0.86
Aberrant subclavian artery as origin of aortic dissection. Eur J Cardiothorac Surg (2008) 0.86
Bacterial mediastinitis after heart transplantation: clinical presentation, risk factors and treatment. J Heart Lung Transplant (2004) 0.86
Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Haematologica (2005) 0.85
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy. J Heart Lung Transplant (2007) 0.85